Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines.

× No keyword cloud information.

8 in total

1. DISC ELECTROPHORESIS IN POLYACRYLAMIDE GELS: EXTENSION TO NEW CONDITIONS OF PH AND BUFFER.

Authors: D E WILLIAMS; R A REISFELD
Journal: Ann N Y Acad Sci Date: 1964-12-28 Impact factor: 5.691

2. Electrophoretic characterization of bacterial polyribosomes in agarose-acrylamide composite gels.

Authors: A E Dahlberg; C W Dingman; A C Peacock
Journal: J Mol Biol Date: 1969-04-14 Impact factor: 5.469

3. Physico-chemical properties of sapoalbin and their relation to the foam stability.

Authors: R Vochten; P Joos; R Ruyssen
Journal: J Pharm Belg Date: 1969 May-Jun

4. Thinlayer chromatographic fingerprinting of commercially available saponins.

Authors: K Dalsgaard
Journal: Dan Tidsskr Farm Date: 1970

5. Disc electrophoresis of ribonucleic acid in polyacrylamide gels.

Authors: E G Richards; J A Coll; W B Gratzer
Journal: Anal Biochem Date: 1965-09 Impact factor: 3.365

6. Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to DEAE-dextran and saponin adjuvanted vaccines.

Authors: E C Anderson; R C Masters; G N Mowat
Journal: Res Vet Sci Date: 1971-07 Impact factor: 2.534

7. Double-disc electrophoresis of proteins.

Authors: D Racusen
Journal: Nature Date: 1967-03-04 Impact factor: 49.962

8. [The active therapeutic principle of horse chestnut (Aesculus hippocastanum). Part 2. On the chemistry of the active substance].

Authors: P PATT; W WINKLER
Journal: Arzneimittelforschung Date: 1960-04

8 in total

17 in total

1. Prevention of rotavirus infections in vitro with aqueous extracts of Quillaja Saponaria Molina.

Authors: Michael R Roner; Ka Ian Tam; Melody Kiesling-Barrager
Journal: Future Med Chem Date: 2010-07 Impact factor: 3.808

2. Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi.

Authors: Yong-Jae Kim; Pengfei Wang; Mauricio Navarro-Villalobos; Bridget D Rohde; JohnMark Derryberry; David Y Gin
Journal: J Am Chem Soc Date: 2006-09-13 Impact factor: 15.419

3. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

Authors: J P Langeveld; J I Casal; A D Osterhaus; E Cortés; R de Swart; C Vela; K Dalsgaard; W C Puijk; W M Schaaper; R H Meloen
Journal: J Virol Date: 1994-07 Impact factor: 5.103

4. Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16.

Authors: G J Fernando; B Murray; J Zhou; I H Frazer
Journal: Clin Exp Immunol Date: 1999-03 Impact factor: 4.330

5. Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant.

Authors: David Y Gin; Susan F Slovin
Journal: Curr Drug ther Date: 2011-08

6. Structure of immune stimulating complex matrices and immune stimulating complexes in suspension determined by small-angle x-ray scattering.

Authors: Jan Skov Pedersen; Cristiano L P Oliveira; Henriette Baun Hübschmann; Lise Arleth; Søren Manniche; Nicolai Kirkby; Hanne Mørck Nielsen
Journal: Biophys J Date: 2012-05-15 Impact factor: 4.033

7. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.

Authors: R Bomford
Journal: Clin Exp Immunol Date: 1980-02 Impact factor: 4.330

8. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.

Authors: R Bomford
Journal: Clin Exp Immunol Date: 1980-02 Impact factor: 4.330

9. Recombinant vaccine for canine parvovirus in dogs.

Authors: J A López de Turiso; E Cortés; C Martínez; R Ruiz de Ybáñez; I Simarro; C Vela; I Casal
Journal: J Virol Date: 1992-05 Impact factor: 5.103

10. Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.

Authors: Robyn Marty-Roix; Gregory I Vladimer; Kimberly Pouliot; Dan Weng; Rachel Buglione-Corbett; Kim West; John D MacMicking; Jonathan D Chee; Shixia Wang; Shan Lu; Egil Lien
Journal: J Biol Chem Date: 2015-11-10 Impact factor: 5.157